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Introduction
Venous thromboembolism (VTE), which includes deep ve-
nous thrombosis (DVT) and its sequelae pulmonary embolism
(PE), are the leading causes of morbidity and mortality
following surgical procedures. The incidence of DVT varies
from 10 to 70% in inpatients.1Death from DVT is attributed to
massive PE, which causes asmany as 300,000 deaths annually
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Abstract Introduction Although venous thromboembolism (VTE) is seen with morbidity and
mortality in various surgical specialties, scarce data are available in the head and neck
surgery domain.
Objective We aim to determine the incidence of VTE in patients receiving surgery for
head and neck cancer.
Methods Four hundred thirteen patients who underwent head and neck surgery
procedures between 2005 and 2013 were reviewed retrospectively. All patients with
head and neck surgery had received thromboprophylaxis (i.e., compression stockings
and subcutaneous heparin). Patient demographics, operating time, and length of
hospital stay were analyzed. The incidence of symptomatic deep venous thrombosis
(DVT) and pulmonary embolism (PE) during the initial postoperative hospitalization was
assessed.
Results Twelve patients were identiﬁed who developed VTE. Three patients developed
DVT, and nine developed PE. The incidence of DVT and PE was 0.72 and 2.17%,
respectively. Interestingly, all of these patients had undergone excision of extensive
head and neck cancers accompanied by a reconstructive procedure. Patients who
developed PE had a longer hospital stay compared with those who only had DVT. There
were overall three mortalities in the nine patients who developed PE.
Conclusion Although VTE has a low incidence, it is a known complication of extensive
head and neck surgeries with life-threatening outcomes. We recommend early mobili-
zation and physiotherapy with the possible aid from appropriate mechanical and
pharmacologic thromboprophylaxis.
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in the United States.2 Hospitalized patients are particularly at
high risk, and PE is one of the most common preventable
causes of hospital deaths.3 In cancer patients, the rates of
recurrent VTE are at least 3 times that of patients without
cancer.4,5 Although numerous effectivemethods are available
for reducing and even preventing DVT and PE, studies have
shown that only 21 to 35% of the surgeons take appropriate
prophylactics steps to prevent DVT and PE for their
patients.6,7
Patients with head and neck cancer usually undergo
comprehensive resection and reconstruction and frequently
exhibit many of the major risk factors for DVT and PE. These
risk factors include advanced age, obesity, dyslipidemia,
immobility because of a prolonged surgical procedure or
extended hospital stay, and addiction like smoking and
alcohol.1 Malignant disease itself can predispose to a hyper-
coagulable state secondary to polycythemia vera.8–10 The
issue of DVT and PE has received little attention in otolaryn-
gology and head and neck surgery literature, and limited data
are available about the incidence of VTE. Very few studies
have evaluated the incidence of DVT and PE in head and neck
surgery. Incidences of 0.6 and 0.4% for DVT and PE, respec-
tively, have been reported for patients having head and neck
surgery, and head and neck cancer, old age, and lack of DVT
prophylaxis were identiﬁed as independent risk factors.11
Factors such as low socioeconomic condition, illiteracy,
and lack of resources pose a profound impact on good-quality
patient care in third-world countries like Pakistan. As there is
no report or study conducted on this issue in our part of
world, our knowledge of the true incidence and contributing
risk factors is limited in the ﬁeld of otolaryngology. The
purpose of this study was to determine the overall incidence
of DVT and PE and to identify speciﬁc risk factors.
Materials and Methods
This was a retrospective review of all head and neck oncologic
operations between 2005 and 2013. We identiﬁed and includ-
ed all those inpatients who underwent head and neck proce-
dures and developed either DVT, PE, or both as postoperative
complications based on International Classiﬁcation ofDiseases-
9 and -10 coding system. Patients received subcutaneously
low-molecular-weight heparin (LMWH) as prophylactic anti-
coagulation (5,000 U) alongwith Tedd stockings an hour before
procedure. Patient demographics including age, sex, weight,
operating time, and length of hospital stay were analyzed.
Other variables like obesity, hyperlipidemia, prior radiation,
and previous head and neck surgeries were recorded. We risk
stratiﬁed our patients with VTE based on a protocol for the
incidence of VTE (►Table 1).1,12Duration of surgical procedure
was recorded from the time of skin incision till closure of skin.
Only those cases using either pedicled or free ﬂaps were
considered as reconstruction. The incidence of symptomatic
DVT and PE during the initial postoperative hospitalizationwas
calculated. Patientswere not routinely screenedwith biochem-
ical or imaging studies; only patientswith symptomatic DVTor
PE (e.g., lower extremity pain or swelling, shortness of breath,
chest pain, tachycardia, fever, etc.) were evaluated accordingly.
The diagnosis of DVT was conﬁrmed by venous Doppler
ultrasonography, whereas the diagnosis of PE was conﬁrmed
by a spiral computed tomographic scan of the chest.
A t test was used for comparison of means of variables like
age and length of surgery, Fisher exact test for gender and
reconstruction, and Mann Whitney U test for weight. A
p value of <0.05 was considered signiﬁcant. Statistical analy-
sis was performed using SPSS for Windows, version 16 (SPSS
Inc., Chicago, Illinois, United States).
Results
A total of 413 head and neck procedures were performed at
our institution. The mean age of these patients was 47 years
(  8.29; range, 33 to 73). There were 265 men (64.2%) and
148 women (35.8%).
Out of 413 patients, only 12 developed VTE (i.e., either DVT
or PE). Reconstruction was performed in 194 patients and
interestingly, all these 12 patients had undergone head and
neck reconstruction. Three patients developed DVT, for an
incidence of 0.72%, and nine developed PE, for an incidence of
2.17% (►Table 2).
Eight patients who developed VTE had stage IV disease
(66%), and the rest were stage III. Of the 12 who developed
VTE, 9 were men (75%) and 3 were women (25%). In patients
who had VTE, the mean age was 55.33 years, and those
without VTE had mean age of 47.52 years, which was
signiﬁcant (►Table 3). Similarly, mean length of surgery
was 10.83 hours for patients who developed VTE and only
6.92 hours for others, which was also statistically signiﬁcant.
The mean weight of patients with VTE was 63.90 kg, a
statistically signiﬁcant difference compared with patients
Table 1 Venous thromboembolism risk stratiﬁcation
Risks Patient stratification
Low Minor surgery in patients
age < 40 y
Moderate Minor surgery in patients with
other risksa or surgery in patients
aged 40–60 y without other risks
High Age > 60 y or 40–60 y with other risks
Highest Multiple risk factors
aRisks include surgery, trauma, immobility, malignancy, cancer therapy
older age, pregnancy, medical illness, cardiac or pulmonary failure,
obesity, smoking, coagulopathy, among others.
Table 2 Incidence of DVT and PE in head and neck cancer
surgery patients
Total no. of patients 413
DVT (n) 3
DVT incidence (%) 0.72
PE (n) 9
PE incidence (%) 2.17
Abbreviations: DVT, deep venous thrombosis; PE, pulmonary embolism.
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without VTE (55.32 kg). Day 4 was the mean postoperative
day of presentation of VTE. Day 3 was the average postopera-
tive day of mobilization. The mean length of hospital stay for
patients with DVT was 9.7 days; however, for patients with
PE, it was 20.9 days.
Nine of 12 patients had either hypertension or diabetes
mellitus or both but none of them were obese or hyper-
lipidemic. Three patients had no comorbidity. None of our
patients had previous history of thrombosis or other cardio-
vascular diseases. Of the 9 patients who had PE, there were 3
in-house deaths most likely secondary to myocardial infarc-
tion or arrhythmias. In all cases, symptomatic DVT or PE was
initially treated with intravenous heparin infusion, which
was later replaced by warfarin.
Two of our patients fell into the moderate-risk group and
remaining 10 patients fell into the high-risk group. All 12
patients received thromboprophylaxis including the 3 who
died. The prophylaxis used was heparin (5,000 U/h) before
surgery and twice daily postoperatively.
Discussion
The overall incidence of DVT and PE in our review of patients
havinghead and neck surgery at our tertiary carehospitalwas
low compared with that of other surgical specialities. In
patients having abdominal surgery and receiving heparin
prophylaxis, the reported frequency of DVT and PE is 9 and
1.3%, respectively.8However, in patients not receiving throm-
boprophylaxis, the estimated incidence is 15 to 30% for
DVT1,13 and from 0.5 to 1.6% for PE.1,11 Among vascular
surgery, the reported incidence of VTE was 2.5 to 2.9%.12
The incidence of DVT in gynecologic surgery ranges from
10 to 40% without routine use of thromboprophylaxis.14,15 In
plastic surgery, the incidence of VTE after abdominoplasty
has been reported as 1.4%,16 and after rhytidectomy, the
incidence of VTE was 0.35%.17 Orthopedic surgery is known
to have a postoperative incidence of DVT that exceed 50% and
rate of PE as high as 12.9%.13,18
In a study by Moreano et al,11 300 patients had head and
neck reconstruction and none of them developed DVT or PE
postoperatively in contrast to our study where we had 12
patientswith VTE. In our study, therewere 194 head and neck
reconstruction surgeries, resulting in 3 cases of symptomatic
DVT (0.72%) and 9 cases of PE (2.17%). Chen and colleagues
found a fourfold increase in incidence of VTE in patient
undergoing head and neck reconstruction compared with
those of non–head and neck reconstruction.19 Our rate of
0.72% for DVT is slightly higher than that reported by Innis
and Anderson.20 A reason often cited for these higher rates of
thromboembolic events in patients undergoing head and
neck surgical procedure is that they are usually elderly
patients with more serious comorbid conditions, which
ultimately increases the likely hood of the development of
DVT and PE. Over 70% of our patients with VTE were above
50 years, and only one patient was younger than 40 years. It
was of interest that all our patients who developed VTE issues
were thosewho had head and neck reconstruction donewith
no history of any previous treatments. Although the rate of
internal jugular vein thrombosis after neck dissection ranges
from 15 to 33%,21,22 in our study we have not done postoper-
ative computed tomography, high-resolution ultrasound, or
color-ﬂow Doppler study, and we cannot comment on inter-
nal jugular or subclavian vein thrombosis.
By looking at our length of operating time in the VTE
group, surgery lasted for more than 10 hours, which was
statistically signiﬁcant. Moreano and colleagues found that
themajority of their patients with VTE had operations lasting
over 2 hours.11We also found statistical signiﬁcance in terms
of weight in patients with VTE, similar to Moreano et al, who
found that almost 47% of their patients were above 80 kg.11
When considering these results all together, it seems that
patientswhowere older andwhounderwent longer head and
neck cancer surgery are at greater risk of developing VTE.
These ﬁnding are consistent with current recommended
guidelines for VTE prophylaxis that emphasize age and length
of operating time as risk factors.1,11,23
As we included only patients who were symptomatic
(lower extremity pain or swelling, shortness of breath, chest
pain, tachycardia) and asymptomatic patients were not rou-
tinely screened with biochemical or imaging studies, it is
possible that we have missed many patients and the actual
incidence of VTE could be higher. When comparing the
morbidity and mortality of our patients with VTE, we found
that patientswho developedDVT had a shortermean hospital
stay than that of patients with PE (9.7 days for DVT and 20.9
days for PE). Similar ﬁnding were also reported by Lee and
colleagues24; however, their patients with PE stayed for over
36 days compared with our stay of almost 21 days. When
comparing our results, we found that our incidence of PEwas
much higher than the other studies (►Table 4).
One important factor that seriously contributes to lack of
mobilization and disuse of Tedd stockings is patient com-
pliance. Despite constant counseling, a majority of our
patients have a misconception that early mobilization
will seriously hinder the healing process. The intensely
hot and humid environment is an additional factor and
discourages patients from moving around as well as from
using Tedd stockings.
Table 3 Statistical analysis of patients with VTE
Variables Patients
with
VTE (n ¼ 12)
Patients
without
VTE (n ¼ 401)
p Value
Mean age (y) 55.33 47.52 0.001
Mean length
of surgery (h)
10.83 6.92 <0.001
Sex
Male
Female
9
3
256
145
0.5
Reconstruction
Yes
No
12
0
182
219
<0.001
Mean
weight (kg)
63.90 55.32 0.041
Abbreviation: VTE, venous thromboembolism.
International Archives of Otorhinolaryngology Vol. 19 No. 3/2015
Venous Thromboembolism Ali et al.202
The literature clearly describes the risk factors for patients
developing VTE and also that the use of thromboprophylaxis
decreases the rate of DVT and PE.1,2,25 There are speciﬁc
recommendations for other surgical specialities, but unfortu-
nately not for otolaryngology speciﬁcally. Understanding guide-
lines and recommendations from other specialities will help us
to make more appropriate decisions for our patients.
For patients with cancer who are undergoing major surgery,
the American College of Chest Physicians recommendations
include routine thromboprophylaxis with LMWH 10,000 to
15,000 IU/d. For patients with cancer with additional risk for
VTE, the recommendation is to use LMWH in combination with
mechanical methods such as sequential compression devices.26
Hence, modalities for thromboprophylaxis are both mechanical
and pharmacologic. Mechanical prophylaxis methods such as
elastic (Tedd) stockings, intermittent pneumatic compression
devices, and venous foot pump have been demonstrated to be
effective and safe. These devices counteract stasis, one of the
three aspects of Virchow’s triad.1 Pharmacologic options for
thromboprophylaxis include unfractionated heparin, LMWH,
fondaparinux, and vitamin K antagonists.1,26–28 Warfarin is
not routinely used for DVT prevention in our setup. It is mainly
used once DVT is established.
According to risk stratiﬁcation system, a majority of pa-
tients with head and neck cancer fell into high-risk group
(e.g., elderly patientswith cancer andmultiple comorbidities)
and should be dealt with using aggressive thromboprophy-
laxis.1,12 When compared with no prophylaxis, unfractio-
nated heparin and LMWH have been shown to reduce VTE
risk by at least 60%.8,12,29 Despite the mechanical (Tedd
stocking) and pharmacologic therapy (heparin 5,000 U twice
daily), our patients developed VTE. Pneumatic devices that
help to reduce the intraoperative risks of DVT are unfortu-
nately not freely available at our institution. Meta-analysis
has shown that pneumatic compression devices also decrease
DVT in patients undergoing surgical procedures by over
60%.18 Moreano et al showed that the use of a pneumatic
compression device decreases the likelihood of a thrombo-
embolic event by one fourth.11
To reduce VTE, we recommend mobilizing patients as
early as the second postoperative day. Moreover, intermit-
tent leg exercises, early mobilization, and educating the
patients and nursing staff will further decrease the rate of
VTE.
In summary, challenges to good patient care in Pakistan
include our cultural factors of disbelief, environmental issues
of oppressive heat, and lack of resources like intraoperative
pneumatic devices.
Conclusion
Based on our data, we concur that the rate of symptomatic
VTE in patients with head and neck cancer was relatively low
as compared with reported rates of other surgical specialties
and in general otolaryngology, but it was higher when
compared with other head and neck reconstructive studies.
Because VTE is potentially a detrimental complication in
patients with cancer, we would recommend that all patients
with head and neck cancer surgery should be mobilized very
early, and unless otherwise contraindicated, they should be
dealt with appropriate mechanical and pharmacologic
thromboprophylaxis.
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